C
아이티켐
309710KOSDAQ기초 의약물질 제조업41.5 / 100
Reference Date: 2026-04-13
Financial Score20.0 / 40
News Sentiment12.5 / 25
Momentum2.0 / 20
Disclosure7.0 / 15
AI Analysis: Plunged 38.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Itechem is a CDMO/CMO company with over 20 years of experience, producing pharmaceutical APIs and intermediates, as well as display materials like OLEDs, supplying high-purity products to global clients under K-GMP certification. The company focuses on organic synthesis technology and is expanding into next-generation drug development, including oligonucleotides and oligopeptides.
Number of Employees
133people
Average Salary
55.1M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
—Industry Average 1.203.5Point
ROE
—Industry Average 8.003.5Point
Debt Ratio
—Industry Average 100.004.0Point
Detailed News Sentiment
5 totalPositive 0Neutral 0Negative 0
- Neutral
- Neutral
- Neutral
Detailed Momentum
52-week position1.0Point
Near 52w low (10%, downtrend)
Current 21,000Won52-week high 49,70052-week low 17,620
1-month return0.0Point
1m -38.51% (strong drop)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
14 totalPositive 0Neutral 13Negative 1
- Neutral[기재정정]정기주주총회결과 (속회)2026-04-09
- Neutral사업보고서 (2025.12)2026-04-07
- Neutral주요사항보고서(자기전환사채만기전취득결정)2026-04-07
- Neutral[기재정정]연결감사보고서 (2024.12)2026-04-06
- Neutral감사보고서제출2026-04-06